LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EQUITY FLASH L impact Sep 28, 2026, 11:57 AM UTC

Nvidia CEO Jensen Huang to appear on CNBC

Jensen Huang is due on CNBC shortly.

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

QQQ

Related stories

Danske Bank A/S (DANSKE) Discloses PDMR Transactions Danske Bank reported transactions by persons discharging managerial responsibilities. APMH Invest A/S is selling shares pro rata alongside the bank’s ongoing share buy-back program L impact | EQUITY | Sep 28, 2026, 12:49 PM UTC Danske Bank A/S, transactions by persons discharging managerial responsibilities 25 September 2026Notification no. 76/2026Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation.In L impact | EQUITY | Sep 28, 2026, 12:49 PM UTC RBC Capital maintains Outperform rating on Karman Holdings, $70 price target RBC Capital maintained their Outperform rating on Karman Holdings's stock with a price target of $70.00.The price target implies an upside of 96.1% from the Sep 25 close of $35.69. L impact | EQUITY | Sep 28, 2026, 12:48 PM UTC RBC Capital reiterates Outperform rating on AAR, $145 price target RBC Capital reiterated their Outperform rating on AAR's stock with a price target of $145.00.The price target implies an upside of 24.9% from the Sep 25 close of $116.11.Key takeaw H impact | EQUITY | Sep 28, 2026, 12:47 PM UTC Telos wins $13.7 million HHS cyber risk management contract The 18-month task order covers deployment of Telos' FedRAMP High-authorized Xacta platform for HHS. M impact | EQUITY | Sep 28, 2026, 12:46 PM UTC Mirum hepatitis drug lowers virus levels in late-stage study Brelovitug met the main goal in chronic hepatitis delta virus patients, with 56% and 45% response rates versus 0% in delayed treatment at 24 weeks. M impact | EQUITY | Sep 28, 2026, 12:45 PM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.